Bavarian Nordic has agreed with Orion Pharma to acquire the Finnish pharmaceutical company’s production facility and administrative offices located in Kvist-gaard, Denmark, 30 km north of Copenhagen. The total investment will be approximately USD 40 million. The site will be re-designed for vaccine production with a capacity to produce up to 120 million doses per year, thus making Bavarian Nordic one of the largest vaccine producers in Europe. The new vaccine facility will be ready for manufacture in 2005 and initially will produce vaccines against smallpox for the US and European markets along with various planned vaccines against HIV. The company’s production partnership with the German vaccine manufacturer IDT will continue and be expanded.
Looking for more projects or tenders?
Subscribe to our Project Preview Newsletter